 | • レポートコード：MRC2-11QY11023 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、91ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は基底細胞がん（BCC）治療薬のグローバル市場について調査・分析したレポートです。種類別（手術、放射線療法、光線力学療法、薬物）市場規模、用途別（小売薬局、病院薬局、がん研究所）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別基底細胞がん（BCC）治療薬の競争状況、市場シェア ・世界の基底細胞がん（BCC）治療薬市場：種類別市場規模 2015年-2020年（手術、放射線療法、光線力学療法、薬物） ・世界の基底細胞がん（BCC）治療薬市場：種類別市場規模予測 2021年-2026年（手術、放射線療法、光線力学療法、薬物） ・世界の基底細胞がん（BCC）治療薬市場：用途別市場規模 2015年-2020年（小売薬局、病院薬局、がん研究所） ・世界の基底細胞がん（BCC）治療薬市場：用途別市場規模予測 2021年-2026年（小売薬局、病院薬局、がん研究所） ・北米の基底細胞がん（BCC）治療薬市場分析：米国、カナダ ・ヨーロッパの基底細胞がん（BCC）治療薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの基底細胞がん（BCC）治療薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の基底細胞がん（BCC）治療薬市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの基底細胞がん（BCC）治療薬市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Sun Pharmaceuticals、Bausch Health、Mylan、F. Hoffmann-La Roche、Merck ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Basal Cell Carcinoma (BCC) is a form of non-melanocytic skin cancer that arises from basal cells, the small, round cells present in the lower epidermis. Around 85% of BCCs occur on the face, head and neck. BCCs usually do not spread or metastasize to other parts of body, they become life threatening by metastasis only in extremely rare cases. According to the American Cancer Society, BCCs constitute around 80% of all non-melanoma skin cancers. Australia has been found to have the highest rate of basal cell carcinoma across the globe. Exposure to ultraviolet radiation is considered as the major cause behind BCC. Use of immunosuppressant drugs further enhance the chances of BCC as the immune system is compromised. White people are more vulnerable to BCC comparatively, according to a research published in the British Medical Journal. The symptoms of BCCs include waxy papules (slightly transparent bump) with pearly appearance and central depression and bleeding from the papules.
The increase in geriatric population, giving rise to numerous skin diseases, such as actinic keratosis and other non-melanoma skin malignancies, is another important factor that has been fueling the demand for basal cell carcinoma treatment substantially. In addition to these, the market is expected to gain considerably from the changing lifestyle of people in developing economies over the coming years as it is anticipated to drive demand for better disease treatments, which in turn, is likely to provide lucrative opportunities for the companies operating in the global basal cell carcinoma treatment market.
Market Analysis and Insights: Global Basal Cell Carcinoma Therapeutics Market
The global Basal Cell Carcinoma Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Basal Cell Carcinoma Therapeutics Scope and Market Size
Basal Cell Carcinoma Therapeutics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Basal Cell Carcinoma Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Sun Pharmaceuticals
Bausch Health
Mylan
F. Hoffmann-La Roche
Merck
…
Market segment by Type, the product can be split into
Surgery
Radiation Therapy
Photodynamic Therapy
Drugs
Market segment by Application, split into
Retail Pharmacies
Hospitals Pharmacies
Cancer Research Institutes
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Basal Cell Carcinoma Therapeutics Revenue
1.4 Market by Type
1.4.1 Global Basal Cell Carcinoma Therapeutics Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Surgery
1.4.3 Radiation Therapy
1.4.4 Photodynamic Therapy
1.4.5 Drugs
1.5 Market by Application
1.5.1 Global Basal Cell Carcinoma Therapeutics Market Share by Application: 2020 VS 2026
1.5.2 Retail Pharmacies
1.5.3 Hospitals Pharmacies
1.5.4 Cancer Research Institutes
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Basal Cell Carcinoma Therapeutics Market Perspective (2015-2026)
2.2 Global Basal Cell Carcinoma Therapeutics Growth Trends by Regions
2.2.1 Basal Cell Carcinoma Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Basal Cell Carcinoma Therapeutics Historic Market Share by Regions (2015-2020)
2.2.3 Basal Cell Carcinoma Therapeutics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Basal Cell Carcinoma Therapeutics Market Growth Strategy
2.3.6 Primary Interviews with Key Basal Cell Carcinoma Therapeutics Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Basal Cell Carcinoma Therapeutics Players by Market Size
3.1.1 Global Top Basal Cell Carcinoma Therapeutics Players by Revenue (2015-2020)
3.1.2 Global Basal Cell Carcinoma Therapeutics Revenue Market Share by Players (2015-2020)
3.1.3 Global Basal Cell Carcinoma Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Basal Cell Carcinoma Therapeutics Market Concentration Ratio
3.2.1 Global Basal Cell Carcinoma Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Basal Cell Carcinoma Therapeutics Revenue in 2019
3.3 Basal Cell Carcinoma Therapeutics Key Players Head office and Area Served
3.4 Key Players Basal Cell Carcinoma Therapeutics Product Solution and Service
3.5 Date of Enter into Basal Cell Carcinoma Therapeutics Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Basal Cell Carcinoma Therapeutics Historic Market Size by Type (2015-2020)
4.2 Global Basal Cell Carcinoma Therapeutics Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Basal Cell Carcinoma Therapeutics Market Size by Application (2015-2020)
5.2 Global Basal Cell Carcinoma Therapeutics Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Basal Cell Carcinoma Therapeutics Market Size (2015-2020)
6.2 Basal Cell Carcinoma Therapeutics Key Players in North America (2019-2020)
6.3 North America Basal Cell Carcinoma Therapeutics Market Size by Type (2015-2020)
6.4 North America Basal Cell Carcinoma Therapeutics Market Size by Application (2015-2020)
7 Europe
7.1 Europe Basal Cell Carcinoma Therapeutics Market Size (2015-2020)
7.2 Basal Cell Carcinoma Therapeutics Key Players in Europe (2019-2020)
7.3 Europe Basal Cell Carcinoma Therapeutics Market Size by Type (2015-2020)
7.4 Europe Basal Cell Carcinoma Therapeutics Market Size by Application (2015-2020)
8 China
8.1 China Basal Cell Carcinoma Therapeutics Market Size (2015-2020)
8.2 Basal Cell Carcinoma Therapeutics Key Players in China (2019-2020)
8.3 China Basal Cell Carcinoma Therapeutics Market Size by Type (2015-2020)
8.4 China Basal Cell Carcinoma Therapeutics Market Size by Application (2015-2020)
9 Japan
9.1 Japan Basal Cell Carcinoma Therapeutics Market Size (2015-2020)
9.2 Basal Cell Carcinoma Therapeutics Key Players in Japan (2019-2020)
9.3 Japan Basal Cell Carcinoma Therapeutics Market Size by Type (2015-2020)
9.4 Japan Basal Cell Carcinoma Therapeutics Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Basal Cell Carcinoma Therapeutics Market Size (2015-2020)
10.2 Basal Cell Carcinoma Therapeutics Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Basal Cell Carcinoma Therapeutics Market Size by Type (2015-2020)
10.4 Southeast Asia Basal Cell Carcinoma Therapeutics Market Size by Application (2015-2020)
11 India
11.1 India Basal Cell Carcinoma Therapeutics Market Size (2015-2020)
11.2 Basal Cell Carcinoma Therapeutics Key Players in India (2019-2020)
11.3 India Basal Cell Carcinoma Therapeutics Market Size by Type (2015-2020)
11.4 India Basal Cell Carcinoma Therapeutics Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Basal Cell Carcinoma Therapeutics Market Size (2015-2020)
12.2 Basal Cell Carcinoma Therapeutics Key Players in Central & South America (2019-2020)
12.3 Central & South America Basal Cell Carcinoma Therapeutics Market Size by Type (2015-2020)
12.4 Central & South America Basal Cell Carcinoma Therapeutics Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Sun Pharmaceuticals
13.1.1 Sun Pharmaceuticals Company Details
13.1.2 Sun Pharmaceuticals Business Overview
13.1.3 Sun Pharmaceuticals Basal Cell Carcinoma Therapeutics Introduction
13.1.4 Sun Pharmaceuticals Revenue in Basal Cell Carcinoma Therapeutics Business (2015-2020))
13.1.5 Sun Pharmaceuticals Recent Development
13.2 Bausch Health
13.2.1 Bausch Health Company Details
13.2.2 Bausch Health Business Overview
13.2.3 Bausch Health Basal Cell Carcinoma Therapeutics Introduction
13.2.4 Bausch Health Revenue in Basal Cell Carcinoma Therapeutics Business (2015-2020)
13.2.5 Bausch Health Recent Development
13.3 Mylan
13.3.1 Mylan Company Details
13.3.2 Mylan Business Overview
13.3.3 Mylan Basal Cell Carcinoma Therapeutics Introduction
13.3.4 Mylan Revenue in Basal Cell Carcinoma Therapeutics Business (2015-2020)
13.3.5 Mylan Recent Development
13.4 F. Hoffmann-La Roche
13.4.1 F. Hoffmann-La Roche Company Details
13.4.2 F. Hoffmann-La Roche Business Overview
13.4.3 F. Hoffmann-La Roche Basal Cell Carcinoma Therapeutics Introduction
13.4.4 F. Hoffmann-La Roche Revenue in Basal Cell Carcinoma Therapeutics Business (2015-2020)
13.4.5 F. Hoffmann-La Roche Recent Development
13.5 Merck
13.5.1 Merck Company Details
13.5.2 Merck Business Overview
13.5.3 Merck Basal Cell Carcinoma Therapeutics Introduction
13.5.4 Merck Revenue in Basal Cell Carcinoma Therapeutics Business (2015-2020)
13.5.5 Merck Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Basal Cell Carcinoma Therapeutics Key Market Segments
Table 2. Key Players Covered: Ranking by Basal Cell Carcinoma Therapeutics Revenue
Table 3. Ranking of Global Top Basal Cell Carcinoma Therapeutics Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Basal Cell Carcinoma Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Surgery
Table 6. Key Players of Radiation Therapy
Table 7. Key Players of Photodynamic Therapy
Table 8. Key Players of Drugs
Table 9. Global Basal Cell Carcinoma Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 10. Global Basal Cell Carcinoma Therapeutics Market Size by Regions (US$ Million): 2020 VS 2026
Table 11. Global Basal Cell Carcinoma Therapeutics Market Size by Regions (2015-2020) (US$ Million)
Table 12. Global Basal Cell Carcinoma Therapeutics Market Share by Regions (2015-2020)
Table 13. Global Basal Cell Carcinoma Therapeutics Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 14. Global Basal Cell Carcinoma Therapeutics Market Share by Regions (2021-2026)
Table 15. Market Top Trends
Table 16. Key Drivers: Impact Analysis
Table 17. Key Challenges
Table 18. Basal Cell Carcinoma Therapeutics Market Growth Strategy
Table 19. Main Points Interviewed from Key Basal Cell Carcinoma Therapeutics Players
Table 20. Global Basal Cell Carcinoma Therapeutics Revenue by Players (2015-2020) (Million US$)
Table 21. Global Basal Cell Carcinoma Therapeutics Market Share by Players (2015-2020)
Table 22. Global Top Basal Cell Carcinoma Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Basal Cell Carcinoma Therapeutics as of 2019)
Table 23. Global Basal Cell Carcinoma Therapeutics by Players Market Concentration Ratio (CR5 and HHI)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Basal Cell Carcinoma Therapeutics Product Solution and Service
Table 26. Date of Enter into Basal Cell Carcinoma Therapeutics Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Basal Cell Carcinoma Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 29. Global Basal Cell Carcinoma Therapeutics Market Size Share by Type (2015-2020)
Table 30. Global Basal Cell Carcinoma Therapeutics Revenue Market Share by Type (2021-2026)
Table 31. Global Basal Cell Carcinoma Therapeutics Market Size Share by Application (2015-2020)
Table 32. Global Basal Cell Carcinoma Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 33. Global Basal Cell Carcinoma Therapeutics Market Size Share by Application (2021-2026)
Table 34. North America Key Players Basal Cell Carcinoma Therapeutics Revenue (2019-2020) (Million US$)
Table 35. North America Key Players Basal Cell Carcinoma Therapeutics Market Share (2019-2020)
Table 36. North America Basal Cell Carcinoma Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 37. North America Basal Cell Carcinoma Therapeutics Market Share by Type (2015-2020)
Table 38. North America Basal Cell Carcinoma Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 39. North America Basal Cell Carcinoma Therapeutics Market Share by Application (2015-2020)
Table 40. Europe Key Players Basal Cell Carcinoma Therapeutics Revenue (2019-2020) (Million US$)
Table 41. Europe Key Players Basal Cell Carcinoma Therapeutics Market Share (2019-2020)
Table 42. Europe Basal Cell Carcinoma Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 43. Europe Basal Cell Carcinoma Therapeutics Market Share by Type (2015-2020)
Table 44. Europe Basal Cell Carcinoma Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 45. Europe Basal Cell Carcinoma Therapeutics Market Share by Application (2015-2020)
Table 46. China Key Players Basal Cell Carcinoma Therapeutics Revenue (2019-2020) (Million US$)
Table 47. China Key Players Basal Cell Carcinoma Therapeutics Market Share (2019-2020)
Table 48. China Basal Cell Carcinoma Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 49. China Basal Cell Carcinoma Therapeutics Market Share by Type (2015-2020)
Table 50. China Basal Cell Carcinoma Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 51. China Basal Cell Carcinoma Therapeutics Market Share by Application (2015-2020)
Table 52. Japan Key Players Basal Cell Carcinoma Therapeutics Revenue (2019-2020) (Million US$)
Table 53. Japan Key Players Basal Cell Carcinoma Therapeutics Market Share (2019-2020)
Table 54. Japan Basal Cell Carcinoma Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 55. Japan Basal Cell Carcinoma Therapeutics Market Share by Type (2015-2020)
Table 56. Japan Basal Cell Carcinoma Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 57. Japan Basal Cell Carcinoma Therapeutics Market Share by Application (2015-2020)
Table 58. Southeast Asia Key Players Basal Cell Carcinoma Therapeutics Revenue (2019-2020) (Million US$)
Table 59. Southeast Asia Key Players Basal Cell Carcinoma Therapeutics Market Share (2019-2020)
Table 60. Southeast Asia Basal Cell Carcinoma Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 61. Southeast Asia Basal Cell Carcinoma Therapeutics Market Share by Type (2015-2020)
Table 62. Southeast Asia Basal Cell Carcinoma Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 63. Southeast Asia Basal Cell Carcinoma Therapeutics Market Share by Application (2015-2020)
Table 64. India Key Players Basal Cell Carcinoma Therapeutics Revenue (2019-2020) (Million US$)
Table 65. India Key Players Basal Cell Carcinoma Therapeutics Market Share (2019-2020)
Table 66. India Basal Cell Carcinoma Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 67. India Basal Cell Carcinoma Therapeutics Market Share by Type (2015-2020)
Table 68. India Basal Cell Carcinoma Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 69. India Basal Cell Carcinoma Therapeutics Market Share by Application (2015-2020)
Table 70. Central & South America Key Players Basal Cell Carcinoma Therapeutics Revenue (2019-2020) (Million US$)
Table 71. Central & South America Key Players Basal Cell Carcinoma Therapeutics Market Share (2019-2020)
Table 72. Central & South America Basal Cell Carcinoma Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 73. Central & South America Basal Cell Carcinoma Therapeutics Market Share by Type (2015-2020)
Table 74. Central & South America Basal Cell Carcinoma Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 75. Central & South America Basal Cell Carcinoma Therapeutics Market Share by Application (2015-2020)
Table 76. Sun Pharmaceuticals Company Details
Table 77. Sun Pharmaceuticals Business Overview
Table 78. Sun Pharmaceuticals Product
Table 79. Sun Pharmaceuticals Revenue in Basal Cell Carcinoma Therapeutics Business (2015-2020) (Million US$)
Table 80. Sun Pharmaceuticals Recent Development
Table 81. Bausch Health Company Details
Table 82. Bausch Health Business Overview
Table 83. Bausch Health Product
Table 84. Bausch Health Revenue in Basal Cell Carcinoma Therapeutics Business (2015-2020) (Million US$)
Table 85. Bausch Health Recent Development
Table 86. Mylan Company Details
Table 87. Mylan Business Overview
Table 88. Mylan Product
Table 89. Mylan Revenue in Basal Cell Carcinoma Therapeutics Business (2015-2020) (Million US$)
Table 90. Mylan Recent Development
Table 91. F. Hoffmann-La Roche Company Details
Table 92. F. Hoffmann-La Roche Business Overview
Table 93. F. Hoffmann-La Roche Product
Table 94. F. Hoffmann-La Roche Revenue in Basal Cell Carcinoma Therapeutics Business (2015-2020) (Million US$)
Table 95. F. Hoffmann-La Roche Recent Development
Table 96. Merck Company Details
Table 97. Merck Business Overview
Table 98. Merck Product
Table 99. Merck Revenue in Basal Cell Carcinoma Therapeutics Business (2015-2020) (Million US$)
Table 100. Merck Recent Development
Table 101. Research Programs/Design for This Report
Table 102. Key Data Information from Secondary Sources
Table 103. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Basal Cell Carcinoma Therapeutics Market Share by Type: 2020 VS 2026
Figure 2. Surgery Features
Figure 3. Radiation Therapy Features
Figure 4. Photodynamic Therapy Features
Figure 5. Drugs Features
Figure 6. Global Basal Cell Carcinoma Therapeutics Market Share by Application: 2020 VS 2026
Figure 7. Retail Pharmacies Case Studies
Figure 8. Hospitals Pharmacies Case Studies
Figure 9. Cancer Research Institutes Case Studies
Figure 10. Basal Cell Carcinoma Therapeutics Report Years Considered
Figure 11. Global Basal Cell Carcinoma Therapeutics Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Basal Cell Carcinoma Therapeutics Market Share by Regions: 2020 VS 2026
Figure 13. Global Basal Cell Carcinoma Therapeutics Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Basal Cell Carcinoma Therapeutics Market Share by Players in 2019
Figure 16. Global Top Basal Cell Carcinoma Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Basal Cell Carcinoma Therapeutics as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Basal Cell Carcinoma Therapeutics Revenue in 2019
Figure 18. North America Basal Cell Carcinoma Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Basal Cell Carcinoma Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Basal Cell Carcinoma Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Basal Cell Carcinoma Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Basal Cell Carcinoma Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Basal Cell Carcinoma Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Basal Cell Carcinoma Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Bottom-up and Top-down Approaches for This Report
Figure 26. Data Triangulation
Figure 27. Key Executives Interviewed
高度腎細胞癌治療薬の世界市場（～2026年） Advanced renal cell carcinoma is associated with a type of kidney cancer that appears in the covering of the proximal complex tubule. The convoluted tubule is a very small part of tubes in the kidney that helps in transportation of unwanted particles from the blood to the urine. Advanced renal cell …- 基底細胞母斑症候群治療薬の世界市場（～2026年） Market Analysis and Insights: Global Basal Cell Nevus Syndrome Drug Market The global Basal Cell Nevus Syndrome Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Basal Cell Nevus Syndrome Drug Scope and Market Size …
- 腎細胞がん治療薬の世界市場（～2026年） Renal cell carcinoma (RCC) is a kidney cancer that originates in the lining of the proximal convoluted tubule, a part of the very small tubes in the kidney that transport primary urine. RCC is the most common type of kidney cancer in adults, responsible for approximately 90–95% of cases.The drug is …
- ナチュラルキラー細胞療法の世界市場（～2026年） Cell therapy, a new therapeutic approach that uses a patient's own immune cells to attack tumors, has emerged as one of the most promising breakthroughs in cancer treatment. NK cells are the body's first line of defense against infections and diseases with an innate ability to rapidly seek and destr…
- 頭頸部扁平上皮がん (HNSCC)治療の世界市場（～2026年） Head and neck cancer usually occurs in the squamous cells present inside the mouth, nose and throat. These squamous cells are usually known as squamous cell carcinoma of the head and neck. Market Analysis and Insights: Global Squamous Cell Carcinoma of the Head and Neck Treatment Market The global S…